Taurus Asset Management LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,054 shares of the biopharmaceutical company’s stock after selling 73 shares during the quarter. Regeneron Pharmaceuticals accounts […]
US Bancorp DE grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,941 shares of the biopharmaceutical company’s stock after acquiring an additional 310 shares during […]
3Chopt Investment Partners LLC bought a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 599 shares of the biopharmaceutical company’s stock, valued at approximately $526,000. Several other institutional investors and hedge funds have also recently modified their […]
Intech Investment Management LLC increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 119.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 18,593 shares of the biopharmaceutical company’s stock after purchasing an additional 10,104 shares during the quarter. Intech Investment Management […]
Johnson Financial Group Inc. cut its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 22.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 867 shares of the biopharmaceutical company’s stock after selling 256 shares during the period. Johnson Financial Group Inc.’s […]